Pulmonary hypertension during high-dose GM-CSF therapy of autoimmune pulmonary alveolar proteinosis.

IF 2.2 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Pulmonary Circulation Pub Date : 2024-11-21 eCollection Date: 2024-10-01 DOI:10.1002/pul2.70020

Ali Ataya, Stephen Mitchel, Brenna Carey, Jeffrey Sippel, Cormac McCarthy, Bruce C Trapnell

引用次数: 0

查看原文本刊更多论文

大剂量 GM-CSF 治疗自身免疫性肺泡蛋白沉着症期间的肺动脉高压。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pulmonary Circulation Medicine-Pulmonary and Respiratory Medicine

CiteScore

4.20

自引率

11.50%

发文量

153

审稿时长

15 weeks

期刊介绍： Pulmonary Circulation''s main goal is to encourage basic, translational, and clinical research by investigators, physician-scientists, and clinicans, in the hope of increasing survival rates for pulmonary hypertension and other pulmonary vascular diseases worldwide, and developing new therapeutic approaches for the diseases. Freely available online, Pulmonary Circulation allows diverse knowledge of research, techniques, and case studies to reach a wide readership of specialists in order to improve patient care and treatment outcomes.